HHS: Medicare incentives, penalties for hospitals could help stem drug shortages
Fierce Healthcare
APRIL 3, 2024
The program, and its complementary effort targeting manufacturers, would require new authorities from Congress.
Fierce Healthcare
APRIL 3, 2024
The program, and its complementary effort targeting manufacturers, would require new authorities from Congress.
Fierce Healthcare
NOVEMBER 6, 2023
Another white paper released by Inovalon and Harvard Medical School highlights the benefits Medicare Advantage enrollees enjoy over traditional Medicare counterparts.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
JANUARY 19, 2024
Traditional Medicare’s bar for reimbursing long-term care hospitals (LTCH) for severely ill, “high-cost outlier” patients has spiked under current payment policies. |
PharmD Live
FEBRUARY 18, 2025
WASHINGTON, February 18, 2025 PharmD Live , an innovative pharmacist-led virtual care solution powered by AI-driven algorithms, announces the release of its recent white paper, Maximizing Shared Savings for Payviders: ACOs, IDNs, At-Risk Provider Groups and Clinics. Download the white paper here.
Pharmaceutical Technology
JANUARY 17, 2023
Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The post Hospital Universitario and Josep Carreras develop cell therapy for leukaemia appeared first on Pharmaceutical Technology.
pharmaphorum
FEBRUARY 15, 2021
The overall aim of the alliance – which will see Healthware work alongside the NCI’s Pascale Hospital – is to develop digital health tools that will deliver “more precise and accessible treatments to patients”, said the partners in a statement.
Pharmaceutical Technology
DECEMBER 8, 2022
In December last year, the first centre in Japan received authorisation to administer the therapy, while six regional hospitals are currently approved to offer this treatment. The delivery of the product is anticipated to begin early next year.
Let's personalize your content